The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Inactivated Vaccines Market During The 2026–2030 Period?
The inactivated vaccines market size has experienced consistent growth in recent years. It is anticipated to expand from $6.37 billion in 2025 to $6.61 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 3.9%. This historical growth can be attributed to factors such as an increasing incidence of infectious diseases, advancements in virology research, government funding allocated for immunization, the expansion of healthcare infrastructure, and public awareness campaigns promoting vaccination.
The inactivated vaccines market is anticipated to experience robust expansion over the coming years. It is projected to reach $8.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This growth during the forecast period can be attributed to an increasing geriatric population, enhanced healthcare access in emerging markets, technological advancements in vaccine delivery systems, a rise in global immunization initiatives, and the greater adoption of multi-dose and combination vaccines. Key trends anticipated in this period include advancements in vaccine formulation, the expansion of cold chain logistics, a growing demand for pediatric vaccines, an increase in government immunization programs, and the development of combination vaccines.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
What Primary Factors Are Fueling The Expansion Of The Inactivated Vaccines Market?
The rising occurrence of infectious diseases is anticipated to boost the expansion of the inactivated vaccine market moving forward. These diseases are conditions initiated by pathogens such as bacteria, viruses, fungi, or parasites, capable of spreading between individuals and causing a broad spectrum of symptoms and health complications. Tuberculosis serves as an example of an infectious disease. Inactivated vaccines operate by employing non-living pathogens to induce an immune response, effectively preventing diseases like polio, hepatitis A, and influenza. For illustration, an article released by the Centers for Disease Control and Prevention, a US-based national public health agency, in November 2023, indicated that the count of tuberculosis patients in the USA climbed from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. Hence, the increasing prevalence of infectious diseases is a key factor driving the growth of the inactivated vaccine market.
How Are Different Segment Groups Identified Within The Inactivated Vaccines Market?
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
Which Trends Are Shaping The Inactivated Vaccines Market Landscape?
Major companies operating in the inactivated vaccines market are concentrating on extending product launches and securing regulatory clearances to bolster their global vaccine portfolios and satisfy increasing immunization requirements. For instance, in April 2024, Sanofi S.A., a France-based healthcare company, introduced Verorab, its inactivated rabies vaccine, in the UK for use across all age groups in both pre-exposure and post-exposure situations. This launch highlights the company’s ongoing efforts to broaden its range of inactivated vaccines and strengthen its global immunization offerings. The move also reflects increasing investments and rising regulatory momentum surrounding inactivated vaccine development and approvals. As more companies advance similar products and broaden their portfolios, these strategic initiatives are collectively driving significant growth in the inactivated vaccines market, supporting wider protection against infectious diseases.
Who Are The Leading Firms Participating In The Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd.
Access The Complete Inactivated Vaccines Market Report:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Which Region Is The Primary Market For The Inactivated Vaccines Market?
North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Inactivated Vaccines Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2026, By The Business Research Company
Inactivated Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model